Share this article

The medical devices industry continues to be a hotbed of patent innovation. Activity is driven by increased need for homecare, preventative treatments, early diagnosis, reducing patient recovery times and improving outcomes, as well as a growing importance in technologies, such as machine learning, augmented reality, 5G, and digitalization. In the last three years alone, there have been over 710,000 patents filed and granted in the medical devices industry, according to GlobalData’s report on Internet of Things in medical: dosage monitoring inhalatorsBuy the report here.

Smarter leaders trust GlobalData

However, not all innovations are equal and nor do they follow a constant upward trend. Instead, their evolution takes the form of an S-shaped curve that reflects their typical lifecycle from early emergence to accelerating adoption, before finally stabilizing and reaching maturity.

Identifying where a particular innovation is on this journey, especially those that are in the emerging and accelerating stages, is essential for understanding their current level of adoption and the likely future trajectory and impact they will have.

30+ innovations will shape the medical devices industry

According to GlobalData’s Technology Foresights, which plots the S-curve for the medical devices industry using innovation intensity models built on over 155,000 patents, there are 30+ innovation areas that will shape the future of the industry.

Within the emerging innovation stage, programmable infusion devices, wearable sleep assistance devices, and context-aware patient monitoring are disruptive technologies that are in the early stages of application and should be tracked closely. Remote dialysis monitoring, NFC implants, and medical ERS are some of the accelerating innovation areas, where adoption has been steadily increasing. Among maturing innovation areas is body area network (BAN), which is now well established in the industry.

Innovation S-curve for Internet of Things in the medical devices industry

Dosage monitoring inhalators is a key innovation area in Internet of Things.

Dosage monitoring inhalators are a device that diffuses drugs into a patient's lungs. they contains sensors to monitor and track the dosage to ensure the patient is receiving what has been recommended by the physician. Metered dose inhalers (MDIs) are available as nasal or oral inhalers, which are valued by patients on therapy related to respiratory illnesses, such as asthma or chronic obstructive pulmonary disease.

GlobalData’s analysis also uncovers the companies at the forefront of each innovation area and assesses the potential reach and impact of their patenting activity across different applications and geographies.  According to GlobalData, there are 90+ companies, spanning technology vendors, established medical devices companies, and up-and-coming start-ups engaged in the development and application of dosage monitoring inhalators.

Key players in dosage monitoring inhalators– a disruptive innovation in the medical devices industry

‘Application diversity’ measures the number of applications identified for each patent. It broadly splits companies into either ‘niche’ or ‘diversified’ innovators.

‘Geographic reach’ refers to the number of countries each patent is registered in. It reflects the breadth of geographic application intended, ranging from ‘global’ to ‘local’.

Patent volumes related to dosage monitoring inhalators

Company Total patents (2010 - 2022) Premium intelligence on the world's largest companies
C. H. Boehringer Sohn AG & Co KG 464 Unlock Company Profile
Teva Pharmaceutical Industries Ltd 296 Unlock Company Profile
AptarGroup Inc 273 Unlock Company Profile
GSK plc 100 Unlock Company Profile
Pneuma Respiratory Inc 77 Unlock Company Profile
Recipharm AB 68 Unlock Company Profile
Koninklijke Philips NV 55 Unlock Company Profile
MannKind Corp 52 Unlock Company Profile
MicroBase Technology Corp 52 Unlock Company Profile
Metall Zug AG 48 Unlock Company Profile
British American Tobacco Plc 44 Unlock Company Profile
Syqe Medical Ltd 43 Unlock Company Profile
ResMed Inc 41 Unlock Company Profile
Chiesi Farmaceutici SpA 38 Unlock Company Profile
Adherium Ltd 33 Unlock Company Profile
Becton Dickinson and Co 32 Unlock Company Profile
Laboratoires Thea SA 32 Unlock Company Profile
Charoen Pokphand Group Co Ltd 28 Unlock Company Profile
Shl Medical Ag 17 Unlock Company Profile
Johnson & Johnson 15 Unlock Company Profile
GoFire Inc 14 Unlock Company Profile
Trudell Medical International 14 Unlock Company Profile
WellO2 Oy 13 Unlock Company Profile
Proveris Scientific Corp 12 Unlock Company Profile
Cipla Ltd 12 Unlock Company Profile
Heitkamp & Thumann KG 12 Unlock Company Profile
Teleflex Inc 12 Unlock Company Profile
Embracer Group AB 12 Unlock Company Profile
Philip Morris International Inc 11 Unlock Company Profile
iDTx Systems, Inc. 10 Unlock Company Profile
Qualcomm Inc 10 Unlock Company Profile
Intellectual Ventures Management LLC 10 Unlock Company Profile
Convexity Scientific LLC 10 Unlock Company Profile
Novartis AG 10 Unlock Company Profile
Mystic Pharmaceuticals Inc 9 Unlock Company Profile
Sulzer Mixpac AG 9 Unlock Company Profile
Nipro Corp 8 Unlock Company Profile
Glatton Sp zoo 8 Unlock Company Profile
MediTuner AB 8 Unlock Company Profile
Pneumoflex Systems LLC 8 Unlock Company Profile
Amiko Digital Health Ltd 7 Unlock Company Profile
Sanofi 7 Unlock Company Profile
Inhalation Sciences Sweden AB 7 Unlock Company Profile
Materialise NV 7 Unlock Company Profile
Sumitomo Chemical Co Ltd 7 Unlock Company Profile
Daikyo Seiko Ltd 7 Unlock Company Profile
Hava Health Inc 7 Unlock Company Profile
SipNose 6 Unlock Company Profile
Francisco Partners Management LLC 6 Unlock Company Profile
Alphabet Inc 6 Unlock Company Profile

Source: GlobalData Patent Analytics

C. H. Boehringer Sohn and Teva Pharmaceutical Industries are two of the leading patent filers in dosage monitoring inhalators. Some other leading patent filers include AptarGroup, GSK, Recipharm, Pneuma Respiratory, Recipharm, and Koninklijke Philips.

In terms of application diversity, Materialise leads the pack, followed by Syqe Medical and British American Tobacco. By geographic reach, Syqe Medical holds the top position, followed by Pneuma Respiratory and Teva Pharmaceutical Industries in second and third spots, respectively.

The market for dosage monitoring inhalators will be driven by increased access to medication across multiple therapeutic areas for a broader spectrum of patients and the development of combination products while ensuring affordability.

To further understand the key themes and technologies disrupting the medical devices industry, access GlobalData’s latest thematic research report on Medical Devices.

Premium Insights


The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.


GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

GlobalData’s Patent Analytics tracks patent filings and grants from official offices around the world. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies across the world’s largest industries.